Summary of Significant Accounting Policies - Additional Information (Detail) |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2021
USD ($)
|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2021
USD ($)
|
Dec. 31, 2021
USD ($)
|
|
Summary Of Significant Accounting Policies [Line Items] | |||||
Maturity period of highly liquid investments | three months or less | ||||
Realized gains or losses on marketable securities | $ 18 | $ 0 | $ 18 | $ 0 | |
Number of securities in unrealized loss position for more than 12 months | 0 | 0 | 0 | 0 | |
Grants receivable recognized | $ 900,000 | $ 3,700,000 | $ 5,200,000 | $ 7,700,000 | |
Grants receivable | 600,000 | 600,000 | $ 4,100,000 | ||
Grants remaining to be awarded | 8,500,000 | 8,500,000 | |||
Level 1 [Member] | |||||
Summary Of Significant Accounting Policies [Line Items] | |||||
Liabilities | 0 | 0 | |||
Level 2 [Member] | |||||
Summary Of Significant Accounting Policies [Line Items] | |||||
Liabilities | $ 0 | $ 0 |
X | ||||||||||
- Definition Decrease in research and development expenses related to grants recognized. No definition available.
|
X | ||||||||||
- Definition Grants remaining to be awarded. No definition available.
|
X | ||||||||||
- Definition Highly Liquid Investments Maturity Period No definition available.
|
X | ||||||||||
- Definition Receivable from grants for costs incurred. No definition available.
|
X | ||||||||||
- Definition Summary of Significant Accounting Policies [Line Items] No definition available.
|
X | ||||||||||
- Definition Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Fair value of financial and nonfinancial obligations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI). No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|